Expert Provider Reviews

Affordable, women-specific hair loss treatment from a trusted public telehealth brand - built on FDA-approved minoxidil

• Built on FDA-approved minoxidil, the first-line treatment for female-pattern loss
• Among the most affordable women's hair-loss options from a trusted brand
• Women-specific lineup with convenient formats (gummies, chews, drops, foam)

Affordable, trusted hair loss treatment from the biggest name in telehealth - FDA-approved finasteride and minoxidil

• Trusted, mainstream brand with real scale and a top-rated app
• Built on the two FDA-approved hair-loss drugs and the most evidence-backed combination
• Among the most affordable entry prices in telehealth hair loss

Dermatologist-founded custom Rx hair growth made for women - age-tailored formulas

• Women-specific formulas that treat female-pattern loss correctly
• Age-tailored: spironolactone for under-50, finasteride/dutasteride reserved for 50+
• Dermatologist-founded with ongoing clinical support

The most-studied drug-free hair growth supplement - no prescription, dermatologist-recommended

• The most clinically studied hair supplement we have reviewed
• Completely drug-free - no prescription and no sexual-side-effect risk
• Multi-pathway approach (DHT, stress, nutrition and inflammation)

Dermatologist-founded custom Rx hair growth - finasteride, minoxidil and dutasteride in one formula

• Dermatologist-founded with a real LA clinical practice behind it
• Maximum customization - combine minoxidil, finasteride, dutasteride, tretinoin and more in one formula
• Offers stronger options most rivals do not: dutasteride and 8% minoxidil

Brand-name GLP-1s (Wegovy, Ozempic, Zepbound) from a NYSE-listed telehealth brand — cash-pay, women-focused

• Offers real, FDA-approved brand-name GLP-1s (Wegovy, Ozempic, Zepbound) — no longer reliant on compounded copies
• Transparent cash pricing from $149/month for medication, accessible versus uninsured brand-name list prices
• Backed by a NYSE-listed, profitable parent (~$2.35B 2025 revenue, 2.5M+ subscribers) with a renewed Novo Nordisk supply deal

Psychologist-reviewed ADHD diagnosis in all 50 states, with medication management where state law allows

• $199 psychologist-reviewed diagnostic evaluation available in all 50 states
• Assessment validated in a peer-reviewed study (Journal of Clinical Psychiatry, October 2025)
• Only LegitScript-certified provider in our ADHD roster, plus BBB accreditation and a clean legal record

Primary-care telehealth with a structured 3-appointment ADHD pathway and unusually transparent stimulant prescribing rules

• Structured 3-appointment diagnostic protocol treats diagnosis as a clinical outcome, not a product
• Accepts many PPO insurance plans; about 75% of insured patients pay $40 or less per appointment
• Publishes its controlled-substance state restrictions plainly instead of hiding them

Cash-pay marketplace of independent ADHD prescribers with the best consumer ratings in our roster

• Lowest entry cost in our ADHD roster: evaluations typically $100-150, follow-ups ~$59, no subscription
• Best consumer ratings we tracked: Trustpilot 4.5/5 (~503 reviews) and Reviews.io 4.96/5 (1,373 reviews)
• You choose your own provider from a marketplace of independent licensed clinicians, and switching is easy

Hybrid clinic + telehealth ADHD care for kids and adults, with the broadest insurance coverage on our roster

• Formal ADHD testing and evaluation for both children and adults, not just a prescriber intake
• Prescribes stimulants (methylphenidates and amphetamines), with hundreds of clinics to satisfy in-person requirements where they apply
• Accepts 250+ commercial insurance plans plus many state plans